Page last updated: 2024-10-31

nafamostat and ADPKD

nafamostat has been researched along with ADPKD in 1 studies

nafamostat: inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Maruyama, H1
Miyakawa, Y1
Gejyo, F1
Arakawa, M1

Other Studies

1 other study available for nafamostat and ADPKD

ArticleYear
Anaphylactoid reaction induced by nafamostat mesilate in a hemodialysis patient.
    Nephron, 1996, Volume: 74, Issue:2

    Topics: Anaphylaxis; Anticoagulants; Benzamidines; Equipment Failure; Female; Guanidines; Humans; Kidney Fai

1996